GRAIL, Inc. has grown revenue 38% a year over three years and 38% a year over five. Revenue growth, 3-year annual rate: +38% (Diagnostics & Research median +8.4%). Revenue growth, 5-year rate: +38%, growth has slowed since the five-year average. Years of annual history on file: 4, FY2022 to FY2025, as filed.

GRALGRAIL, Inc.

Healthcare

$140.55+255% 1Y

$140.55

$41.6552 weeks$153.92

Is it growing?

Good

Growing: revenue growing +23% year on year and operating margin widening (+143.6 points).

2 good, 1 without data

Revenue trend+23% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction+143.6 points operating

Trailing-twelve-month operating margin, -338.3% now against -482.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is GRAL growing?

GRAIL, Inc. has grown revenue 38% a year over three years and 38% a year over five.

+38%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +38%
Revenue growth, 5-year rate · +38% over three · growth has slowed since the five-year average
Years of annual history on file: 4
Years of annual history on file · FY2022 to FY2025, as filed

Details›